The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
D J Toobert, S E Hampson, R E Glasgow
https://pubmed.ncbi.nlm.nih.gov/10895844Actively Recruiting
Phase Not Applicable
Age: 18Years +
FEMALE
ID07372872
Development and Feasibility Testing of the MyGlucoCare Smartphone-Based Self-Management Support Program for Women With Gestational Diabetes
Led by Hong Kong Metropolitan University · Updated on 2026-05-22
30
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the "MyGlucoCare" smartphone program designed to support women with gestational diabetes mellitus (GDM). The study's main goal is to test if this program is practical and acceptable for participants, and to observe preliminary effects on diabetes self-management, blood sugar control, and overall well-being. It is a single-arm pilot study involving about 30 pregnant women with GDM. Participants will use the "MyGlucoCare" app for 8 to 12 weeks during pregnancy. The program includes three components: automated personalized education covering GDM management topics, proactive individualized support from a clinician through bi-weekly check-ins and chat responses, and a moderated peer support group to share experiences. Data will be collected before starting, near the end of pregnancy, and postpartum. Women taking part will complete questionnaires, record health data, and some may participate in interviews to share feedback. Researchers will measure engagement with the app, recruitment and retention rates, system usability, self-efficacy, blood glucose levels, physical activity, stress, and pregnancy outcomes. Safety and confidentiality will be maintained throughout, with data collected securely and anonymously.
CONDITIONS
Brief Title
Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
- Pregnant women diagnosed with Gestational Diabetes Mellitus (GDM) via a 75g Oral Glucose Tolerance Test conducted between 24 and 28 weeks of gestation
- Aged 18 years or older
- Own a smartphone with reliable internet access
- Able to read and understand Chinese
You will not qualify if you...
- Pre-existing diagnosis of Type 1 or Type 2 diabetes mellitus
- Known major fetal anomaly
- Concurrent enrollment in any other structured GDM self-management intervention
- Severe mental health conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - 8 to 12 weeks
Participants use the MyGlucoCare smartphone app, which provides personalised education, clinician support, and peer support to help manage gestational diabetes.
Bi-weekly clinician check-ins and ongoing app engagement
Follow-up
Duration - Up to approximately 16 weeks after implementation
Participants complete post-intervention assessments around 36 weeks' gestation and postpartum evaluations 6-12 weeks after delivery to measure outcomes and experiences.
3 data collection points: post-intervention and postpartum assessments conducted remotely
Trial Site Locations
Total: 1 location
1
Hong Kong Metropolitan University
Hong Kong, Hong Kong
Actively Recruiting
Loading map...
Research Team
B
Bronya Luk Assistant Professor, DHSc, MN, BN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Characteristics of the Spanish- and English-Language Self-Efficacy to Manage Diabetes Scales.
Philip L Ritter, Kate Lorig, Diana D Laurent
https://pubmed.ncbi.nlm.nih.gov/26846336Sample size determination with a pilot study.
Ben O'Neill
https://pubmed.ncbi.nlm.nih.gov/35167592The PHQ-9: validity of a brief depression severity measure.
K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941